| 唐溱,姜典卓,赵晓霞,张永文.银杏叶提取物质量标准比较及标准提高思路探讨[J].中国药品标准,2020,21(1):21-25 |
| 银杏叶提取物质量标准比较及标准提高思路探讨 |
| Comparison of different quality standards of Ginkgo Biloba Extract and discussion on improving the quality standards of these extracts |
| 投稿时间：2019-06-25 修订日期：2020-02-05 |
| DOI： |
| 中文关键词: 银杏叶提取物 质量研究 质量标准提高 |
| 英文关键词: GBE quality research quality standard improvement |
| 基金项目: |
|
| 摘要点击次数: 921 |
| 全文下载次数: 130 |
| 中文摘要: |
| 银杏叶提取物（GBE）及其制剂在国内外广泛用于治疗心脑血管疾病。作者通过比较各国药典中GBE质量标准，对不同国家标准中的主要检测指标进行比较，并进一步与另一种GBE—银杏酮酯（GBE50）质量标准作对比分析。在此基础上，作者对GBE质量标准提高思路进行了探讨，目的为提高GBE的质量可控性，也为类似的天然药物提取物质量标准内容的选择提供参考。 |
| 英文摘要: |
| Ginkgo biloba extract (GBE) and its preparations are world-widely used in the treatment of cardiovascular and cerebrovascular diseases. The authors compared several GBE quality standards in different pharmacopoeias, and further analyzed the differences in quality standards of these extracts compared to another ginkgo biloba extract (GBE50). On the basis of above analysis, the authors proposed the possibility of quality standards improvement of these extracts. It is therefore possible to enhance the quality control of GBE and will be helpful for the quality standard establishment of similar natural substance extracts. |
|
查看/发表评论 下载PDF阅读器 |
| 关闭 |